Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-4456

4 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-4456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4456 6

68071 4456 6
Label for Lansoprazole 15 mg delayed-release capsules by NuCare Pharmaceuticals, Inc., displaying the NDC 68071-4456. The label indicates a quantity of 60 capsules, with each oblong capsule having a pink cap and green body, imprinted with 'RDY' on the cap and 'LAN' on the body. It includes manufacturing and storage information, along with a warning to keep out of reach of children.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing the mean severity of day heartburn by study day for evaluable patients, with severity rated from 0 (none) to 3 (severe). The x-axis represents days from the start of treatment, and the y-axis shows mean severity of heartburn. Three lines represent placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, illustrating heartburn severity trends over approximately 60 days.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients.' It compares mean severity scores over 60 days for three groups: Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The vertical axis measures mean severity (0=None to 3=Severe), and the horizontal axis shows days from start of treatment.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lansoprazole, showing the molecular arrangement characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.